Coronavirus Disease 2019 Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections-a Time Series Analysis.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
27 01 2021
Historique:
received: 28 04 2020
accepted: 02 06 2020
entrez: 27 1 2021
pubmed: 28 1 2021
medline: 30 1 2021
Statut: ppublish

Résumé

A time series analysis of 871 543 pediatric emergency visits revealed that the coronavirus disease 2019 (COVID-19) lockdown and school closures were associated with a significant decrease in infectious diseases disseminated through airborne or fecal-oral transmission: common cold, gastroenteritis, bronchiolitis, and acute otitis. No change was found for urinary tract infections.

Identifiants

pubmed: 33501967
pii: 5850910
doi: 10.1093/cid/ciaa710
pmc: PMC7314162
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

319-322

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

François Angoulvant (F)

Assistance Publique-Hôpitaux de Paris, Pediatric Emergency Department, Necker-Enfants Malades University Hospital, Université de Paris, Paris, France.
Inserm, Centre de Recherche des Cordeliers, UMRS 1138, Sorbonne Université, Université de Paris, Paris, France.

Naïm Ouldali (N)

Assistance Publique-Hôpitaux de Paris, Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, Université de Paris, Paris, France.
Assistance Publique-Hôpitaux de Paris, Clinical Epidemiology Unit, Robert Debré University Hospital, ECEVE Inserm UMR 1123, Université de Paris, Paris, France.
Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France.

David Dawei Yang (DD)

Assistance Publique-Hôpitaux de Paris, Pediatric Emergency Department, Necker-Enfants Malades University Hospital, Université de Paris, Paris, France.
Inserm, Centre de Recherche des Cordeliers, UMRS 1138, Sorbonne Université, Université de Paris, Paris, France.

Mathilde Filser (M)

Assistance Publique-Hôpitaux de Paris, Department of Clinical Microbiology, Necker-Enfants Malades University Hospital, Université de Paris, Paris, France.

Vincent Gajdos (V)

Assistance Publique-Hôpitaux de Paris, Pediatric Department, Antoine Béclère University Hospital, Université de Paris Saclay, Clamart, France.
Centre for Research in Epidemiology and Population Health, Inserm UMR1018, Villejuif, France.

Alexis Rybak (A)

Assistance Publique-Hôpitaux de Paris, Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Paris, France.

Romain Guedj (R)

Assistance Publique-Hôpitaux de Paris, Pediatric Emergency Department, Armand Trousseau University Hospital, Sorbonne Université, Paris, France.
Obstetrical, Perinatal and Pediatric Epidemiology Research Team, Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité, Inserm UMR1153 , Université de Paris, Paris, France.

Valérie Soussan-Banini (V)

Assistance Publique-Hôpitaux de Paris, Service de Pédiatrie, Hôpital Ambroise Paré, Boulogne-Billancourt, France.

Romain Basmaci (R)

Assistance Publique-Hôpitaux de Paris, Service de Pédiatrie-Urgences, Hôpital Louis-Mourier, Université de Paris, Colombes, France.
IAME , Inserm UMR1137, Université de Paris, Paris, France.

Alain Lefevre-Utile (A)

Assistance Publique-Hôpitaux de Paris, General Pediatric and Pediatric Emergency Department, Jean Verdier Hospital, Bondy, France.
Inserm U976, Human Systems Immunology and Inflammatory Networks, Saint Louis Research Institute, Université de Paris, Paris, France.

Dominique Brun-Ney (D)

Assistance Publique-Hôpitaux de Paris, Strategy and Transformation Management Department-Emergencies and Intensive Cares, Paris, France.
Assistance Publique-Hôpitaux de Paris, Patient Quality Medical Organisation Departement-Health Crisis Management, Paris, France.

Laure Beaujouan (L)

Assistance Publique-Hôpitaux de Paris, Strategy and Transformation Management Department-Emergencies and Intensive Cares, Paris, France.
Assistance Publique-Hôpitaux de Paris, Patient Quality Medical Organisation Departement-Health Crisis Management, Paris, France.

David Skurnik (D)

Assistance Publique-Hôpitaux de Paris, Department of Clinical Microbiology, Necker-Enfants Malades University Hospital, Université de Paris, Paris, France.
Inserm U1151, Equipe 11, Institut Necker-Enfants Malades, Université de Paris, Paris, France.
Division of Infectious Diseases, Harvard Medical School, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH